You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Slate Run Pharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for SLATE RUN PHARMA, and what generic and branded alternatives to SLATE RUN PHARMA drugs are available?

SLATE RUN PHARMA has twenty-four approved drugs.



Summary for Slate Run Pharma
US Patents:0
Tradenames:22
Ingredients:22
NDAs:24

Drugs and US Patents for Slate Run Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Slate Run Pharma EPTIFIBATIDE eptifibatide INJECTABLE;INJECTION 209864-002 Jan 25, 2019 AP RX No No ⤷  Subscribe ⤷  Subscribe
Slate Run Pharma SODIUM NITROPRUSSIDE sodium nitroprusside SOLUTION;INTRAVENOUS 215846-003 Aug 26, 2022 AP RX No No ⤷  Subscribe ⤷  Subscribe
Slate Run Pharma LURASIDONE HYDROCHLORIDE lurasidone hydrochloride TABLET;ORAL 212091-005 Dec 28, 2020 AB RX No No ⤷  Subscribe ⤷  Subscribe
Slate Run Pharma VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 215821-001 Nov 18, 2021 AP RX No No ⤷  Subscribe ⤷  Subscribe
Slate Run Pharma LURASIDONE HYDROCHLORIDE lurasidone hydrochloride TABLET;ORAL 212091-002 Dec 28, 2020 AB RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.